Page 7 - Heart Transplant Guidelines
P. 7

Heart Function Service: Heart Transplant Guidelines

                    Anaphylaxis: ........................................................................................................................................ 63

                    Infectious Disease Prophylaxis: ........................................................................................................... 64
                    Contraindications: ............................................................................................................................... 64

                    Adverse Reactions: .............................................................................................................................. 64

                  Protocol for Administration of Basiliximab (Simulect®) ......................................................................... 65
                    Dose: ................................................................................................................................................... 65

                    Administration: ................................................................................................................................... 65
                    Side Effects: ......................................................................................................................................... 65

                  Protocol for Administration of Rituximab (Rituxan®) ............................................................................. 66
                    Premedication:  1 hr prior to infusion................................................................................................. 66

                    Dose: ................................................................................................................................................... 66
                    Infusion: .............................................................................................................................................. 66

                    Anaphylaxis: ........................................................................................................................................ 66
                    Drug Interactions: ............................................................................................................................... 66

                    Side Effects: ......................................................................................................................................... 67

                  Protocol for Administration of Intravenous Immunoglobulin (IVIG) ...................................................... 69
                  Protocols for the Administration of Bortezomib (Velcade®) .................................................................. 75

                  Protocol for Administration of Belatacept (Nulojix®) ............................................................................. 78
                  Protocol for Administration of Alemtuzumab (Campath®) .................................................................... 79

                  Protocols for the Administration of Eculizumab (Soliris®) ...................................................................... 80
                  Protocol for Administration of Valganciclovir (Valcyte®) ....................................................................... 82

               Normal Blood Pressure Values.................................................................................................................... 84





























               Updated May 17, 2018                                                                         7
   2   3   4   5   6   7   8   9   10   11   12